Brain Small Chain Fatty Acid Metabolism in Parkinson Disease: Tributyrin Supplementation
Status:
Recruiting
Trial end date:
2024-01-01
Target enrollment:
Participant gender:
Summary
Small exploratory open-label pilot study to assess the short-chain fatty acid (SCFA) prodrug
tributyrin as a potential therapy for persons with Parkinson disease